Recording High Frequency Oscillations in Patients With Tumors and Epilepsy
Launched by UNIVERSITY OF ZURICH · Dec 18, 2014
Trial Information
Current as of August 29, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients intend to be treated at the Klinik für Neurochirurgie
- • Patients fall into one of the patient groups: (1) Patients with symptomatic epilepsy with focal and/or secondary generalized seizures resistant to medication where a neurosurgical resection is considered as an intervention of epilepsy surgery. (2)Patients where a tumor is planned to be resected that has caused preoperative seizures. (3) Patients where a tumor is planned to be resected that has not caused preoperative seizures.
- • Male and Female subjects 18 years to 99 years of age
- • Written informed consent after participants' information
- Exclusion Criteria:
- • contraindications on ethical grounds
- • known or suspected non-compliance, drug or alcohol abuse,
- • enrolment into a clinical trial within last 4 weeks
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Johannes Sarnthein, Prof Dr
Principal Investigator
Universitätsspital Zürich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials